Coherus BioSciencesOfficial website ↗Coherus Oncology is a commercial-stage company advancing next-generation combination therapies to elevate what’s possible for people living with cancer. Source: https://www.coherus.com1 medicine explainedtoripalimabLoqtorziPD-1 checkpoint inhibitorLoqtorzi (toripalimab) is a PD-1 checkpoint inhibitor from Coherus Oncology for nasopharyngeal carcinoma. With cisplatin and gemcitabine it is a first-line treatment of metastatic or recurrent locally advanced disease, and as monotherapy it treats disease that has progressed after platinum chemotherapy.T cells are built to destroy abnormal cells, but many cancers protect themselves by displaying ligands PD-L1 and PD-L2 that bind the PD-1 off-switch o
